TY - JOUR
KW - Humans
KW - Adolescent
KW - *Sulfasalazine/adverse effects
KW - Prognosis
KW - Retrospective Studies
KW - arthritis, psoriatic
KW - arthritis, rheumatoid
KW - sulfasalazine
KW - Treatment
AU - A. Abhishek
AU - M. Grainge
AU - T. Card
AU - H. Williams
AU - M. Taal
AU - G. Aithal
AU - C. Fox
AU - C. Mallen
AU - M. Stevenson
AU - G. Nakafero
AU - R. Riley
AD - Academic Rheumatology, University of Nottingham, Nottingham, UK Abhishek.Abhishek@nottingham.ac.uk.
Lifespan and Population Health, University of Nottingham, Nottingham, UK.
Centre for Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
Translational Medical Sciences, University of Nottingham, Nottingham, UK.
Nottingham NIHR BRC, Nottingham, UK.
School of Meicine, Keele University, Keele, UK.
School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Academic Rheumatology, University of Nottingham, Nottingham, UK.
University of Birmingham, Birmingham, UK.
AN - 38453215
BT - RMD Open
C2 - PMC10921482
DO - 10.1136/rmdopen-2023-003980
DP - NLM
ET - 2024/03/08
LA - eng
M1 - 1
N1 - 2056-5933
Abhishek, Abhishek
Orcid: 0000-0003-0121-4919
Grainge, Matthew
Card, Tim
Orcid: 0000-0003-2555-2250
Williams, Hywel C
Taal, Maarten W
Aithal, Guruprasad P
Fox, Christopher P
Mallen, Christian D
Stevenson, Matthew D
Nakafero, Georgina
Riley, Richard
Journal Article
England
RMD Open. 2024 Mar 7;10(1):e003980. doi: 10.1136/rmdopen-2023-003980.
PY - 2024
SN - 2056-5933
T2 - RMD Open
TI - Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
VL - 10
ER -